Mapping Depression at Single-Cell Resolution: Why the Brain Struggles to Grow New Neurons

Posted on 26 August, 2026 by Mehrdad Fathi

The brains of people with depression appear to be less capable of producing new neurons than those of people without the disorder. That is the headline finding of a study published in Nature Medicine, built on the most comprehensive map yet assembled of cell types in the adult human hippocampus — the brain region central to learning, memory and emotion.

A Twenty-Year-Old Hypothesis Meets Modern Technology

For more than two decades, some researchers have suspected that a disruption in neurogenesis — the process by which the brain generates new neurons — could be involved in depression. What has been missing is the resolution to see exactly where the process breaks down. This study delivers it.

“This paper, excitingly, is the first to show at single-cell resolution exactly where in the process things appear to be awry and what molecular machinery is involved,” says Amelia Eisch, a neuroscientist at the University of Pennsylvania in Philadelphia, who was not involved with the research.

An important caveat comes first: the study does not establish that impaired neurogenesis helps cause depression, and the authors are careful to note that depression involves multiple brain areas, not just the hippocampus. Even so, the findings could point toward new therapeutic strategies. “We found several potentially druggable pathways involved in the pathogenesis,” says Maura Boldrini Dupont, a neuroscientist at Columbia University in New York City and one of the paper’s authors.

Half a Million Cells, One Trajectory

The authors analysed brain tissue collected from 30 people shortly after their deaths. Eleven of the donors had major depressive disorder (MDD), also called clinical depression; nineteen had no mental-health conditions and served as a control group. From these individuals’ hippocampi, the team sequenced RNA in the nuclei of almost 500,000 cells.

This single-nucleus RNA sequencing provides a snapshot of gene activity in each cell. Because scientists know which genes are associated with the various stages of neuronal development, gene activity serves as a molecular marker of cell maturity. Using this information, the team reconstructed what is probably a trajectory of neurogenesis: neural stem cells — cells that can give rise to neurons — become intermediate neural progenitor cells, then develop into neuron precursors known as neuroblasts, and finally into immature neurons.

The comparison between groups was striking. The brains of individuals with MDD contained a greater proportion of neural stem cells and a lower proportion of neuroblasts than those of controls, suggesting the progression from one stage to the next has been impaired. “It looked like the trajectory was stalled, lagging behind,” says Dupont.

A Puzzle Within the Finding

The picture is not entirely straightforward. The study did not detect a lower proportion of immature neurons in MDD compared with controls — which is what one would expect if neurogenesis were fully halted, notes Evgenia Salta, a neuroscientist at the Netherlands Institute for Neuroscience in Amsterdam. “This makes it all the more interesting to zoom in further on how and when the neurogenic process becomes affected along disease progression,” she says.

Animal studies have long suggested a link between neurogenesis and depression-like behaviour. Dupont notes that in mice, blocking neurogenesis can impair the animals’ response to stress and affect learning and memory. In humans, memory itself plays a part in depression: people with the disorder “have altered pattern separation, which is the ability to distinguish between different cues and memories. They tend to focus on negative memories,” she says.

Yet the causal question remains genuinely open. The data cannot answer whether impaired neurogenesis causes depression, whether depression impairs neurogenesis, or whether both share a common cause. “This is still an open question,” says Gerd Kempermann, a neuroscientist at the German Center for Neurodegenerative Diseases in Dresden.

Settling an Older Debate Along the Way

Beyond depression, the work speaks to one of neuroscience’s long-running controversies: whether the adult human brain produces new neurons at all. Some earlier studies failed to detect adult neurogenesis, keeping the debate alive for years. This dataset adds substantial evidence that it does occur — and goes a step further, suggesting these freshly generated neurons not only exist but have a distinct function, says Kempermann, who calls the results “really strong and interesting.”

A Resource Beyond a Single Disease

Researchers in the field also praised the sheer scale and depth of the dataset. Alongside single-nucleus sequencing, the team applied spatial transcriptomics, which maps where different genes are active within brain tissue, and proteomics, which measures the proteins present in the tissue.

“This is undoubtedly an impressive body of work, a true tour de force,” says Salta. “The data offer a wealth of knowledge for further analysis by the neurogenesis community and by researchers in other fields.”

For drug developers and mental-health researchers alike, the message is one of cautious promise: a stalled cellular process, now visible in molecular detail, with several potentially druggable pathways waiting to be explored.

Source: Adapted from Nature news, doi: https://doi.org/10.1038/d41586-026-02661-8

References:

1. Peng, M. S. et al. Nature Med. https://doi.org/10.1038/s41591-026-04571-8 (2026).

2. Jacobs, B. L., van Praag, H. & Gage, F. Mol. Psychiatry 5, 262–269 (2000).

3. Sorrells, S. et al. Nature 555, 377–381 (2018).